MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,970 | +86.7% | 2,250,000 | 0.0% | 0.14% | +76.9% |
| Q1 2023 | $1,591 | -99.9% | 2,250,000 | 0.0% | 0.08% | -12.4% |
| Q4 2022 | $1,687,500 | -12.9% | 2,250,000 | 0.0% | 0.09% | -18.3% |
| Q3 2022 | $1,937,000 | -23.1% | 2,250,000 | 0.0% | 0.11% | -31.9% |
| Q2 2022 | $2,520,000 | -87.2% | 2,250,000 | -63.9% | 0.16% | -77.0% |
| Q2 2021 | $19,739,000 | -5.9% | 6,226,673 | 0.0% | 0.70% | -2.2% |
| Q1 2021 | $20,984,000 | -5.9% | 6,226,673 | 0.0% | 0.71% | -0.7% |
| Q4 2020 | $22,291,000 | +111.1% | 6,226,673 | +54.5% | 0.72% | +96.4% |
| Q3 2020 | $10,558,000 | -14.4% | 4,029,649 | 0.0% | 0.36% | -32.7% |
| Q2 2020 | $12,331,000 | +381.5% | 4,029,649 | +64.4% | 0.54% | +209.7% |
| Q1 2020 | $2,561,000 | – | 2,450,543 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
| Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
| DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
| Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
| Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
| Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
| Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
| Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |